BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blasco H, Bernard-Marissal N, Vourc’h P, Guettard YO, Sunyach C, Augereau O, Khederchah J, Mouzat K, Antar C, Gordon PH. A rare motor neuron deleterious missense mutation in the DPYSL3 (CRMP4) gene is associated with ALS. Hum Mutat. 2013;34:953-960. [PMID: 23568759 DOI: 10.1002/humu.22329] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Ponnusamy R, Lebedev AA, Pahlow S, Lohkamp B. Crystal structure of human CRMP-4: correction of intensities for lattice-translocation disorder. Acta Crystallogr D Biol Crystallogr 2014;70:1680-94. [PMID: 24914979 DOI: 10.1107/S1399004714006634] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
2 Poppe L, Rué L, Robberecht W, Van Den Bosch L. Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS). Experimental Neurology 2014;262:138-51. [DOI: 10.1016/j.expneurol.2014.07.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
3 Tonouchi A, Nagai J, Togashi K, Goshima Y, Ohshima T. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. J Neurochem 2016;137:795-805. [PMID: 26991935 DOI: 10.1111/jnc.13617] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
4 Eira J, Silva CS, Sousa MM, Liz MA. The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders. Prog Neurobiol 2016;141:61-82. [PMID: 27095262 DOI: 10.1016/j.pneurobio.2016.04.007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 10.8] [Reference Citation Analysis]
5 Maimon R, Ankol L, Gradus Pery T, Altman T, Ionescu A, Weissova R, Ostrovsky M, Tank E, Alexandra G, Shelestovich N, Opatowsky Y, Dori A, Barmada S, Balastik M, Perlson E. A CRMP4-dependent retrograde axon-to-soma death signal in amyotrophic lateral sclerosis. EMBO J 2021;40:e107586. [PMID: 34190355 DOI: 10.15252/embj.2020107586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Jain S, Wheeler JR, Walters RW, Agrawal A, Barsic A, Parker R. ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. Cell 2016;164:487-98. [PMID: 26777405 DOI: 10.1016/j.cell.2015.12.038] [Cited by in Crossref: 699] [Cited by in F6Publishing: 528] [Article Influence: 139.8] [Reference Citation Analysis]
7 Rippin I, Eldar-Finkelman H. Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration. Cells 2021;10:262. [PMID: 33572709 DOI: 10.3390/cells10020262] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Umetsu S, Mizukami H, Saito T, Uchida C, Igawa A, Kudo K, Itabashi C, Osonoi S, Danyang G, Sasaki T, Yagihashi S, Hakamada K. Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation. Sci Rep 2020;10:1156. [PMID: 31980687 DOI: 10.1038/s41598-020-57883-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Veyrat-Durebex C, Corcia P, Dangoumau A, Laumonnier F, Piver E, Gordon PH, Andres CR, Vourc'h P, Blasco H. Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis. Mol Neurobiol 2014;49:966-83. [PMID: 24198229 DOI: 10.1007/s12035-013-8573-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
10 Delzor A, Couratier P, Boumédiène F, Nicol M, Druet-Cabanac M, Paraf F, Méjean A, Ploux O, Leleu JP, Brient L, Lengronne M, Pichon V, Combès A, El Abdellaoui S, Bonneterre V, Lagrange E, Besson G, Bicout DJ, Boutonnat J, Camu W, Pageot N, Juntas-Morales R, Rigau V, Masseret E, Abadie E, Preux PM, Marin B. Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme. BMJ Open 2014;4:e005528. [PMID: 25180055 DOI: 10.1136/bmjopen-2014-005528] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
11 Radwan M, Lilley JD, Ang CS, Reid GE, Hatters DM. Immiscible inclusion bodies formed by polyglutamine and poly(glycine-alanine) are enriched with distinct proteomes but converge in proteins that are risk factors for disease and involved in protein degradation. PLoS One 2020;15:e0233247. [PMID: 32857759 DOI: 10.1371/journal.pone.0233247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Feneberg E, Gordon D, Thompson AG, Finelli MJ, Dafinca R, Candalija A, Charles PD, Mäger I, Wood MJ, Fischer R, Kessler BM, Gray E, Turner MR, Talbot K. An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress. Neurobiol Dis 2020;144:105050. [PMID: 32800996 DOI: 10.1016/j.nbd.2020.105050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
13 Carulli D, de Winter F, Verhaagen J. Semaphorins in Adult Nervous System Plasticity and Disease. Front Synaptic Neurosci 2021;13:672891. [PMID: 34045951 DOI: 10.3389/fnsyn.2021.672891] [Reference Citation Analysis]
14 Kanda M, Sugimoto H, Kodera Y. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World J Gastroenterol. 2015;21:10584-10597. [PMID: 26457018 DOI: 10.3748/wjg.v21.i37.10584] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
15 Oya H, Kanda M, Sugimoto H, Shimizu D, Takami H, Hibino S, Hashimoto R, Okamura Y, Yamada S, Fujii T. Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor. J Gastroenterol. 2015;50:590-600. [PMID: 25173447 DOI: 10.1007/s00535-014-0993-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
16 Moloney EB, de Winter F, Verhaagen J. ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front Neurosci 2014;8:252. [PMID: 25177267 DOI: 10.3389/fnins.2014.00252] [Cited by in Crossref: 150] [Cited by in F6Publishing: 146] [Article Influence: 21.4] [Reference Citation Analysis]
17 Boylan K. Familial Amyotrophic Lateral Sclerosis. Neurol Clin 2015;33:807-30. [PMID: 26515623 DOI: 10.1016/j.ncl.2015.07.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 10.7] [Reference Citation Analysis]
18 Marangi G, Traynor BJ. Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges. Brain Res. 2015;1607:75-93. [PMID: 25316630 DOI: 10.1016/j.brainres.2014.10.009] [Cited by in Crossref: 91] [Cited by in F6Publishing: 80] [Article Influence: 13.0] [Reference Citation Analysis]